Evidence-Based Interventions to Enhance Outcomes Among Struggling Readers
NCT ID: NCT04059939
Last Updated: 2024-08-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
542 participants
INTERVENTIONAL
2017-08-01
2024-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy of a Two-Year Intensive Reading Intervention for Middle School English Learners With Reading Difficulties
NCT03695068
Improving Response to Intervention in Students With or at Risk of Reading Disabilities
NCT03261661
Efficacy of Reading Intervention on the Brain Connectivity in Autism
NCT05568056
Comprehensive Program to Improve Reading and Writing Skills in At-Risk and Dyslexic Children
NCT00061412
Tackling Two of the Most Important Unresolved Tasks in Reading Intervention
NCT06403007
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
NOTE: The Covid-19 pandemic emerged mid-project and altered several of our plans for this project, as well as led to a mid-project extension. Specifically, this was designed as a 2-cohort, multi-year intervention study. While Cohort 1 completed all planned milestones and activities, for Cohort 2 the intervention was ongoing when the pandemic closed all schools. A third Cohort was then added when schools reopened, but students in Cohort 3 only received 1 year of the intended 2-year intervention.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Reading Plus Attention Control
Reading
Small group reading instruction
Attention Control (math practice)
Attention Control (math practice)
Reading Plus Anxiety
Reading
Small group reading instruction
Anxiety Management
small group anxiety management skills instruction
BAU
Classroom Business as Usual
Classroom Business as Usual
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Reading
Small group reading instruction
Anxiety Management
small group anxiety management skills instruction
Classroom Business as Usual
Classroom Business as Usual
Attention Control (math practice)
Attention Control (math practice)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Demonstrate difficulty with reading (which is defined as scoring at or below a standard score of 90 on the Gates MacGinite Reading Comprehension Test
* Difficulty with reading must be confirmed by classroom teacher/school
Exclusion Criteria
* Students in life skills classes (due to task appropriateness)
* Students who have an unrelated neurological disorder (e.g., tumor, traumatic brain injury)
* Students who have a severe psychiatric disorder that prevents assessment (e.g., autism), or who have an uncorrected sensory disorder
8 Years
14 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Texas at Austin
OTHER
Boston University Charles River Campus
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Amie E. Grills
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Amie E Grills, PhD
Role: PRINCIPAL_INVESTIGATOR
Boston University
Sharon Vaughn, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Texas at Austin
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Texas at Austin
Austin, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RHD087706A
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.